Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microelectrode arrays enable directional stereo-EEG during kainate-mediated seizures.

bioRxiv : the preprint server for biology·2026
Same author

Gamma suppression correlates with thalamic stimulation therapeutic response in intractable epilepsy.

Epilepsia·2026
Same author

Deep learning enabled decision support systems in epilepsy surgery: a scoping review.

npj health systems·2026
Same author

Cerebrovascular vulnerability and fibrosis in human brain aneurysms.

Nature neuroscience·2026
Same author

Responsive stimulation of the thalamus for idiopathic generalized epilepsy: Results of the randomized controlled NAUTILUS trial through 18 months.

Epilepsia·2026
Same author

International multi-center study to quantify the effect of deep venous drainage after surgical resection of Spetzler-Martin Grade II-III brain arteriovenous malformations.

Neurosurgical review·2026

Related Experiment Video

Updated: Jun 3, 2026

Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection
02:22

Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection

Published on: April 12, 2024

Repeat surgery for hypothalamic hamartoma in refractory epilepsy.

Sandipan Pati1, Adib A Abla, Harold L Rekate

  • 1Division of Neurology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona 85013, USA. sandipan.pati@chw.edu

Neurosurgical Focus
|March 5, 2011
PubMed
Summary
This summary is machine-generated.

Reoperation for hypothalamic hamartoma (HH) epilepsy can significantly reduce seizures in over half of patients when initial surgery fails. This approach offers improved seizure control and cognitive/behavioral benefits for selected HH epilepsy cases.

More Related Videos

Anteromesial Temporal Lobectomy for Medically Intractable Temporal Lobe Epilepsy: An Operative Study
11:29

Anteromesial Temporal Lobectomy for Medically Intractable Temporal Lobe Epilepsy: An Operative Study

Published on: August 15, 2025

Related Experiment Videos

Last Updated: Jun 3, 2026

Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection
02:22

Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection

Published on: April 12, 2024

Anteromesial Temporal Lobectomy for Medically Intractable Temporal Lobe Epilepsy: An Operative Study
11:29

Anteromesial Temporal Lobectomy for Medically Intractable Temporal Lobe Epilepsy: An Operative Study

Published on: August 15, 2025

Area of Science:

  • Neurosurgery
  • Epileptology
  • Neurology

Background:

  • Hypothalamic hamartomas (HHs) frequently cause drug-resistant epilepsy, leading to severe behavioral and cognitive impairments.
  • Initial epilepsy surgery offers seizure resolution in 50%-60% of patients, but limited options exist for those with treatment failure.
  • Reoperation may be a viable strategy to improve seizure outcomes in select patients with recurrent HH epilepsy.

Purpose of the Study:

  • To retrospectively analyze the success rates and complications of reoperations in patients with hypothalamic hamartomas (HHs).
  • To evaluate the efficacy of repeat surgical interventions for refractory epilepsy secondary to HHs.
  • To assess the impact of reoperation on seizure frequency, cognitive function, and behavioral issues in HH patients.

Main Methods:

  • Retrospective review of a surgical database (Barrow Neurological Institute, 2003-2010) for patients with HH epilepsy.
  • Analysis of demographic data, seizure history, presurgical evaluations, and postoperative follow-up for 21 reoperated patients.
  • Surgical treatments included open procedures (transcallosal, orbitozygomatic), endoscopic resection, and radiosurgery.

Main Results:

  • Twenty-one patients (13%) underwent reoperation after initial epilepsy surgery.
  • Over half of patients (67%) experienced a 50%-90% reduction in seizures post-reoperation, with two patients becoming seizure-free.
  • No patients experienced worsened behavioral issues; however, new complications like hemiparesis and thalamic stroke were noted.

Conclusions:

  • Reoperation is a valuable option for selected patients with hypothalamic hamartoma (HH) epilepsy experiencing initial surgical failure.
  • Significant seizure reduction is achievable in a majority of patients undergoing repeat surgery for HH-related epilepsy.
  • Careful patient selection and surgical planning are crucial to optimize outcomes and minimize risks associated with reoperation.